Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

NCT00096486 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: everolimus
DRUG: gefitinib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]